Diagnostic Markets for Women’s Health: Forecasts to 2018 (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing)

    Published: October 30, 2014 | Price: $995.00 – $1,990.00

    Diagnostic Markets for Women's Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing) Kalorama Information’s report on Women's Health Diagnostic Markets takes a solid look at the current and developing world markets for key diagnostic tests aimed at the health of women. The report presents market developments in women's health diagnostics, including in-depth analysis of the following testing fields: Ovarian Cancer Testing Urinary Tract Infections Neonatal Jaundice Autoimmune Disease Cystic Fibrosis...
    Diagnostic Test Service Commercialization in Multiplex and Esoteric Testing: A Roadmap to Diagnostics in the 21st Century

    Published: August 1, 2008 | Price: $1,500.00 – $7,000.00

    Test services, once the norm in the diagnostics industry, then abandoned for reagent sales, are now making a comeback. IVD companies have established cGMP and CLIA-registered labs by which they offer their proprietary tests to physicians, hospitals and reference labs. These tests are outside the oversight of the traditional FDA and CE Mark test commercialization avenue in the U.S, and Europe and so are thought to come to market by what may seem to be the back door. Kalorama has...
    Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease

    Published: October 1, 2003 | Price: $1,496.00 – $2,992.00

    Diagnostic testing for prion diseases has become more important as countries increase the number of tests to battle the potential public health problem. Academic, government, and industry organizations continue to develop diagnostic testing technologies and policies as preventative measures. The number of prion diagnostic technologies being used and developed for prion diseases primarily reflects the scientific and technical challenges of detecting prion proteins. Growth of prion testing will depend on these technology breakthroughs and the future prevalence of prion disease....
    Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease

    Published: December 1, 2003 | Price: $1,496.00 – $2,992.00

    Severe Acute Respiratory Syndrome (SARS), which was a new and unidentified disease when it first affected people, ripped through Asia and Toronto from late 2002 into the summer of 2003, before being contained for the season. Taiwan with just 346 reported cases performed 10,000 diagnostic tests. Three years after West Nile Virus (WNV) first appeared in the United States in 1999 with just 62 cases and 7 deaths, the U.S. Center for Disease Control reports thousands of cases and 150...
    Diagnostics for Emerging Infectious Disease Threats Volume III: Bacterial Disease

    Published: April 1, 2004 | Price: $1,995.00 – $3,990.00

    The recent terrorism events, in addition to the ease of travel that allows infectious diseases to spread, and technology developments drive the renewed interest in clinical and environmental infectious disease diagnostics. The combined public health and bio-terrorism markets of several bacterial and protozoan diseases are estimated to be nearly $100 million. This report, the final volume of the Diagnostics for Emerging Infectious Disease Threats series, focuses on diagnostic testing for 11 bacterial and protozoal diseases in clinical and environmental testing:...
    Diagnostics for Emerging Infectious Disease Threats, Volumes I – III

    Published: March 1, 2004 | Price: $3,995.00 – $7,990.00

    A host of new and old infectious diseases have emerged on the world stage, presenting familiar and novel challenges to public health officials. New strains of once controlled bacteria, new immunocomprimised patient populations, and new bioterror threats have spurred diagnostics companies to develop new tests and kits to meet the demand. Kalorama has assembled the vital data developers and marketers need to understand the competitive and commercial landscape in three volumes: Prion Disease; Viral Disease ; and Baterial & Protozoal...
    Digital Pathology: Markets, Trends, Companies and COVID-19 Impact

    Published: July 24, 2020 | Price: $3,500.00 – $7,000.00

    Digital pathology is the technique of analyzing high-resolution digitally scanned histology images, which may then be analyzed using computational tools and algorithms.  Digital pathology is enabled in part by virtual microscopy, a method of capturing microscopic images and transmitting them over computer networks.  This allows independent viewing of images by large numbers of people in diverse locations. Digital camera equipped microscopes may zoom onto a specific region on a slide to provide higher resolution of the area.  In another strategy,...
    Direct-to-Consumer Pharmaceutical Marketing 2005: Controversies Continue

    Published: April 1, 2005 | Price: $1,995.00 – $3,990.00

    This timely overview of direct to consumer (DTC) pharmaceutical marketing examines the numerous issues surrounding DTC practices and markets, using industry and consumer publications as well as interviews with industry experts. The topics examined include: DTC marketing spending by product, DTC marketing spending by company DTC marketing spending by media channel The ROI debate on the cost-effectiveness of DTC marketing expenditures Arguments for and against DTC marketing by its proponents and critics DTC marketing regulations in the U.S. and selected...
    Direct-to-Consumer Testing Market

    Published: January 14, 2019 | Price: $4,500.00 – $9,000.00

    Direct-to-Consumer Testing Market With advances in technology, the completion of the sequencing of the human genome and the pressures of capitalism, direct to consumer (DTC) laboratory testing is becoming increasingly popular. The growing market for DTC laboratory testing may promote awareness of health issues and genetic diseases, which could allow patients to take a more proactive role in their healthcare. The global DTC testing market is divided into two distinct areas of DTC testing: Routine clinical laboratory testing Medical genetic...
    Direct-to-Consumer Testing Market

    Published: January 14, 2018 | Price: $4,500.00 – $9,000.00

    With advances in technology, the completion of the sequencing of the human genome and the pressures of capitalism, direct to consumer (DTC) laboratory testing is becoming increasingly popular. The growing market for DTC laboratory testing may promote awareness of health issues and genetic diseases, which could allow patients to take a more proactive role in their healthcare. The global DTC testing market is divided into two distinct areas of DTC testing: Routine clinical laboratory testing Medical genetic laboratory testing Kalorama’s...
    Disruption in Healthcare: Amazon, Brexit, Trump, MACRA, Gig Workers, Aging – 27 Factors That Could Change the Business

    Published: March 27, 2018 | Price: $2,995.00 – $5,990.00

      In healthcare, there are 27 potential disruptors that could have a large impact on the market.  This report discusses them and how they will impact markets in healthcare and pharmaceuticals: • New US Healthcare Policies/ACA Status • Reimbursement Changes in Europe and Other Developed Nations • Brexit • Emerging Countries • Demographic Changes • Ransomware and Blockchain Strategies • Telemedicine • Walk-in Clinics • MACRA • Empowered Consumers • "Gig" Economy • Value-Based Reimbursement • Brazilian Biotech Market •...
    DNA Microarray Market Trends (Installed Base, Applications, Purchase Plans and The Impact of Next-Gen Sequencing)

    Published: November 1, 2011 | Price: $150.00 – $300.00

    DNA Microarrays are utilized heavily by research labs for a number of tasks such as gene profiling, RNA detection and SNP analysis. But as Kalorama Information's DNA Market Trends report indicates, the market for these systems is about to experience change. The report authored by Kalorama Information biotech analyst Justin Saeks, is the result of surveys carried out with microarray labs to determine the current state of the microarray market and attempt to predict the future direction of the technologies....
    DNA Sequencing Equipment and Services Markets, 2nd Edition

    Published: August 1, 2009 | Price: $3,800.00 – $7,600.00

    Since the last edition of Kalorama Information's DNA Sequencing Equipment and Services report, the market has been changing in unpredictable ways as second-generation sequencers are being incrementally introduced and upgraded. On the surface, the situation has become somewhat linear and predictable, but as Kalorama Information biotech analyst Justin Saeks explains, it is actually a unique and relatively volatile situation that is not seen often with life science tools markets. Third-generation systems have the potential to completely change the market, or...
    Downstream Bioprocessing Markets (Chromatography Columns and Resins, Membrane Adsorbers, Filtration Systems, Sensors)

    Published: October 2, 2018 | Price: $4,500.00 – $9,000.00

    Downstream Bioprocessing Markets (Chromatography Columns and Resins, Membrane Adsorbers, Filtration Systems, Sensors) Downstream processing, or bioprocessing, involves the recovery and purification of biosynthetic products, often pharmaceuticals, from natural sources. These sources may be animal or plant tissue or fermentation broth. It is an essential step in producing pharmaceuticals, such as antibiotics, hormones (insulin and human growth hormone), antibodies, and vaccines. Downstream Bioprocessing Markets analyzes the current and potential world market for components used in downstream processing, including the global downstream...
    Drug Delivery Markets, 2nd Edition, Vol II: Implantable / Injectable Delivery Systems (Markets for Needle-Free, Targeted Injectable, Sustained-Release Implantable and Other Systems)

    Published: February 1, 2007 | Price: $2,995.00 – $4,990.00

    Fueled by the promise of needle-free mechanisms for vaccine distribution and other pharmaceutical uses, the implantable/injectable drug delivery market is growing rapidly. The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to continued growth. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products. The implantable/injectable delivery drug market is a expected to grow to over $12 billion by 2010. Kalorama’s Drug Delivery Markets. Edition...